Athersys
ATHX
#11123
Rank
S$1.06 M
Marketcap
S$0.01721
Share price
-33.50%
Change (1 day)
-98.91%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -S$56.26 Million

According to Athersys's latest financial reports the company's current earnings are S$0.08 Million. In 2022 the company made an earning of -S$98.15 Million, an increase over its 2021 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$56.26 Million-42.68%
2022 -S$98.15 Million-11.54%
2021 -S$0.12 Billion11.14%
2020 -S$99.84 Million72.2%
2019 -S$57.98 Million77.29%
2018 -S$32.7 Million-22.91%
2017 -S$42.42 Million111.89%
2016 -S$20.02 Million-8.52%
2015 -S$21.89 Million-40.81%
2014 -S$36.98 Million18.62%
2013 -S$31.18 Million
2011 -S$17.57 Million19.71%
2010 -S$14.68 Million-26.28%
2009 -S$19.91 Million-18.21%
2008 -S$24.34 Million-8.28%
2007 -S$26.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.11 B-62,307.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.49 B-25,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.58 B-21,859.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.76 B-18,438.39%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$16.76 B-31,592.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.23 B-23,080.22%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
S$0.21 B-499.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$3.97 Billion 7,351.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-S$0.8 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA